A study reported that dandelion root extract caused extensive death in cultured colon cancer cells within 48 hours. It did not establish a cancer treatment for people.
The distinction is essential when a laboratory result becomes a viral health claim.
What the researchers tested
The 2016 paper in Oncotarget examined a water-based extract using HCT116 and HT-29 colorectal cancer cell lines. Researchers reported programmed cell death in more than 95% of tested cancer cells under their experimental conditions.
They also studied mice carrying human tumor grafts and reported markedly reduced tumor growth. Slowing growth relative to a control group is different from eliminating an equivalent proportion of an existing tumor.
These experiments investigated biological mechanisms and early therapeutic possibilities. They did not measure survival or treatment success in human patients.
Why tea is not the tested treatment
A prepared laboratory extract is not interchangeable with a cup of tea, a root eaten as food or an unstandardized supplement. Concentration, absorption and metabolism all matter.
Memorial Sloan Kettering’s evidence review distinguishes preclinical anticancer findings from established clinical use. NCCIH likewise says compelling evidence for dandelion’s use in treating health conditions is lacking.
People receiving cancer treatment should discuss supplements with their care team because interactions and other risks are possible. The study is a reason for further research, not a basis for replacing proven care.